Univariate analysis | Â | Â | Multivariate analysis (baseline model)* | Multivariate analysis (final model)* | ||
---|---|---|---|---|---|---|
Variable | OR (95% CI) | p | Adjusted OR (95% CI) | p | Adjusted OR (95% CI) | p |
Sex (female vs male) | 1.09 (0.70–2.05) | 0.5 | – | – | – | – |
Diagnosis (PsA vs RA) | 0.80 (0.42–1.52) | 0.5 | – | – | – | – |
Current biologic DMARD | 0.99 (0.58–1.69) | 1.0 | – | – | – | – |
Current methotrexate | 1.31 (0.81–2.12) | 0.3 | – | – | – | – |
Current prednis(ol)one | 0.90 (0.54–1.48) | 0.7 | – | – | – | – |
Current hypertension | 0.58 (0.35–0.98) | 0.04 | 0.65 (0.38–1.11) | 0.11 | – | – |
Current hyperlipidaemia | 1.20 (0.67–2.14) | 0.6 | – | – | – | – |
Current diabetes | 1.04 (0.44–2.49) | 0.9 | – | – | – | – |
Current smoker | 1.22 (0.40–3.73) | 0.7 | – | – | – | – |
Overweight or obese | 0.51 (0.31–0.84) | 0.01 | 0.59 (0.35–0.99) | 0.04 | 0.56 (0.33–0.93) | 0.03 |
University/tertiary education | 1.20 (0.74–1.93) | 0.5 | – | – | – | – |
Full time work or study | 0.98 (0.57–1.66) | 0.9 | – | – | – | – |
Age ≥ 65 years | 1.17 (0.70–1.94) | 0.6 | – | – | – | – |
Disease duration ≥5 years | 0.68 (0.27–1.75) | 0.4 | – | – | – | – |
Low self-reported disease activity (VAS ≤ 20) | 1.88 (1.14–3.09) | 0.01 | 1.69 (1.01–2.82) | 0.05 | 1.71 (1.03–2.85) | 0.04 |
Low pain (VAS ≤20) | 1.57 (0.95–2.61) | 0.08 | – | – | – | – |